Screener
Jasper Therapeutics, Inc. JSPR Q1 2026 Annual earnings
Reported May 14, 2026 · Before market open
EPS-$0.06Beat by $0.40
EPS estimate-$0.46
Next report
Nov 9, 2026 (In 1 week)Revenue estimate$6.0M
EPS estimate-$0.06
Versus estimates
Diluted EPS
FAQ
- When did Jasper Therapeutics, Inc. report Q1 2026 earnings?
- Jasper Therapeutics, Inc. (JSPR) reported Q1 2026 earnings on May 14, 2026 before market open.
- What were Jasper Therapeutics, Inc.'s Q1 2026 revenue and EPS?
- Jasper Therapeutics, Inc. reported eps of $-0.06 for Q1 2026.
- Did Jasper Therapeutics, Inc. beat estimates in Q1 2026?
- EPS beat the consensus estimate of $-0.46 by $0.40.
- How did Jasper Therapeutics, Inc.'s Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 95.7% from $-1.41.
- Where can I find Jasper Therapeutics, Inc.'s Q1 2026 SEC filings?
- You can read the 8-K earnings release (0001213900-26-056596) and the 10-K/A periodic report (0001213900-26-050178) directly on SEC EDGAR. The filing index links above go to sec.gov.
